Proto Labs Inc
For the period ended Dec 31, 2023. Filed Feb 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 16, 2024
PRLB$67.93-1.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 202 and
Consolidated Balance Sheets
(In thousands, except share and per share amounts)
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $83,790 | $56,558 |
| Short-term marketable securities | 19,013 | 23,568 |
| Accounts receivable, net of allowance for doubtful accounts of $2,499 and $1,706 as of December 31, 2023 and December 31, 2022, respectively | 72,848 | 76,225 |
| Inventory | 13,657 | 13,578 |
| Prepaid expenses and other current assets | 9,124 | 12,597 |
| Income taxes receivable | 2,228 | 4,042 |
| Total current assets | 200,660 | 186,568 |
| Property and equipment, net | 253,655 | 257,785 |
| Goodwill | 273,991 | 273,991 |
| Other intangible assets, net | 25,584 | 31,250 |
| Long-term marketable securities | 8,019 | 26,419 |
| Operating lease assets | 4,628 | 3,844 |
| Finance lease assets | 960 | 17,532 |
| Other long-term assets | 4,856 | 4,779 |
| Total assets | $772,353 | $802,168 |
| Liabilities and shareholders' equity | ||
| Current liabilities | ||
| Accounts payable | $15,636 | $17,356 |
| Accrued compensation | 15,292 | 12,743 |
| Accrued liabilities and other | 16,872 | 22,384 |
| Current operating lease liabilities | 1,585 | 1,561 |
| Current finance lease liabilities | 296 | 17,537 |
| Total current liabilities | 49,681 | 71,581 |
| Long-term operating lease liabilities | 3,008 | 2,255 |
| Long-term finance lease liabilities | 595 | - |
| Long-term deferred tax liabilities | 18,742 | 26,322 |
| Other long-term liabilities | 5,032 | 4,362 |
| Total liabilities | 77,058 | 104,520 |
| Shareholders' equity | ||
| Preferred stock, $0.001 par value, authorized 10,000,000 shares; issued and outstanding 0 shares as of December 31, 2023 and December 31, 2022, respectively | - | - |
| Common stock, $0.001 par value, authorized 150,000,000 shares; issued and outstanding 25,721,957 and 26,888,425 shares as of December 31, 2023 and December 31, 2022, respectively | 26 | 27 |
| Additional paid-in capital | 466,884 | 473,740 |
| Retained earnings | 256,398 | 258,236 |
| Accumulated other comprehensive loss | (28,013) | (34,355) |
| Total shareholders' equity | 695,295 | 697,648 |
| Total liabilities and shareholders' equity | $772,353 | $802,168 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.